Literature DB >> 4268858

5-Iodo-2-deoxyuridine resistance of vaccinia viruses in cells endowed with thymidine kinase activity.

M A Marcialis, E Biondi, A Atzeni, M L Schivo, P Uccheddu, B Loddo.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4268858     DOI: 10.1007/bf01944806

Source DB:  PubMed          Journal:  Experientia        ISSN: 0014-4754


× No keyword cloud information.
  5 in total

1.  ISOLATION AND PROPERTIES OF VACCINIA MUTANTS DEFICIENT IN THYMIDINE KINASE-INDUCING ACTIVITY.

Authors:  D R DUBBS; S KIT
Journal:  Virology       Date:  1964-02       Impact factor: 3.616

2.  DEVELOPMENT OF VACCINIA VIRUS RESISTANT TO 5-IODO-2DEOXYURIDINE.

Authors:  B LODDO; M L SCHIVO; W FERRARI
Journal:  Lancet       Date:  1963-11-02       Impact factor: 79.321

3.  DECREASED PATHOGENICITY FOR RABBIT SKIN OF IDU-RESISTANT VACCINIA VIRUS.

Authors:  W FERRARI; G L GESSA; B LODDO; M L SCHIVO
Journal:  Virology       Date:  1965-05       Impact factor: 3.616

4.  Development of resistance to antiviral drugs.

Authors:  H E Renis; D A Buthala
Journal:  Ann N Y Acad Sci       Date:  1965-07-30       Impact factor: 5.691

5.  Incorporation of 5-bromodeoxyuridine and 5-iododeoxyuridine into viral DNA and its effect on the infective process.

Authors:  A S Kaplan; T Benporat; T Kamiya
Journal:  Ann N Y Acad Sci       Date:  1965-07-30       Impact factor: 5.691

  5 in total
  1 in total

1.  Low virulence and immunogenicity in mice and in rabbits of variants of Herpes simplex virus resistant to 5-iodo-2-deoxyuridine.

Authors:  M A Marcialis; P La Colla; M L Schivo; O Flore; A Firinu; B Loddo
Journal:  Experientia       Date:  1975-04-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.